Framing Women, Framing Fetuses: How Britain Regulates Arrangements for the Collection and Use of Aborted Fetuses in Stem Cell Research and Therapies
- 3 December 2007
- journal article
- Published by Springer Nature in BioSocieties
- Vol. 2 (4) , 429-447
Abstract
This article engages with the frequently made claim that the UK has a transparent, accountable and strict but permissive regulatory approach to research usKeywords
This publication has 21 references indexed in Scilit:
- Purity and the dangers of regenerative medicine: Regulatory innovation of human tissue-engineered technologySocial Science & Medicine, 2006
- Embryonic Economies: The Double Reproductive Value of Stem CellsBioSocieties, 2006
- Regulating Hybrids: ‘Making a Mess’ and ‘Cleaning Up’ in Tissue Engineering and Transpecies TransplantationSocial Theory & Health, 2006
- Visualising abortion: emotion discourse and fetal imagery in a contemporary abortion debateSocial Science & Medicine, 2005
- Stem cell therapy: hope or hype?BMJ, 2005
- The acceptability of home medical abortion to women in UK settingsBJOG: An International Journal of Obstetrics & Gynaecology, 2005
- Ethics behind closed doors: do research ethics committees need secrecy?BMJ, 2001
- Bodies of Law1997
- Ethical guidelines for the use of human embryonic or fetal tissue for experimental and clinical neurotransplantation and researchJournal of Neurology, 1994
- EMBRYOS AND PARKINSON'S DISEASEThe Lancet, 1988